department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Shingrix · pharmadog

pharmadog
drugs
Shingrix

drug

patient view →

varicella zoster vaccine

Marketedupdated 2mo ago

by GlaxoSmithKline LLC

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

Shingrix

indication

Herpes Zoster (Shingles)

phase

marketed

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 19m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

Trials studying varicella zoster vaccine

phase2Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Overactive not recruitingn=764
phase2A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adultsterminatedn=484
phase2A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccineactive not recruitingn=467
phase4Recombinant Herpes Zoster Vaccine for Prevention of Cardiovascular Events and Dementianot yet recruitingn=162,000
phase3Shingrix in Renal Transplant Recipientsrecruitingn=132
phase1A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participantscompletedn=150
phase2Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Abovenot yet recruitingn=135
phase2A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individualsrecruitingn=645

more trials →